<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2397">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04514016</url>
  </required_header>
  <id_info>
    <org_study_id>20200802</org_study_id>
    <nct_id>NCT04514016</nct_id>
  </id_info>
  <brief_title>Cross Sectional CFAR HIV/COVID Study</brief_title>
  <official_title>Cross Sectional Survey Of Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (COV-2) Infection And Seroprevalence In A Cohort Of HIV-Infected Children, Youth, And Adolescents Receiving Care At A Single Tertiary Care Medical Center In Miami-Dade County, Florida</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Miami Center for AIDS Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this research study is to learn the rate of SARS COV-2 on HIV infected
      children, adolescents, and youth receiving their primary HIV care at the University of Miami
      Miller School of Medicine. We will be using a Real Time Polymerase Chain Reaction (RT-PCR)
      assay collected by a nasopharyngeal (nose) swab. RT-PCR is a real time test that can detect
      the amount of genetic material of a specific virus.The study is funded by The Miami Center
      for AIDS Research (CFAR)
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 12, 2020</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of participants who tested positive with SARS COV-2 Infection</measure>
    <time_frame>month 3</time_frame>
    <description>SARS COV-2 Infection will be analyzed from nasopharyngeal swab samples via RT-PCR assay</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of participants who tested positive with SARS COV-2 antibody</measure>
    <time_frame>month 3</time_frame>
    <description>SARS COV-2 antibody will be analyzed from blood samples via serological assay</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>SARS-CoV Infection</condition>
  <condition>Covid19</condition>
  <arm_group>
    <arm_group_label>HIV positive participants with positive COVID-19 results</arm_group_label>
    <description>Participants in this group will have a RT-PCR and Coronavirus Disease (COVID) -19 specific antibody testing at baseline, 1 month and 3 month visits.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HIV positive participants with negative COVID-19 results</arm_group_label>
    <description>Participants in this group will have a RT-PCR and COVID-19 specific antibody testing at baseline only.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood, Nasopharyngeal swab samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        HIV-positive pediatric, adolescent or young adult being treated at Batchelor Children
        Research Institute (BCRI) at the University of Miami.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Being a patient to the Pediatric or Adolescent clinic located at Batchelor Children
             Research Institute (BCRI)

          -  Being diagnosed with HIV infection by the time of enrollment

          -  At enrollment, 3 to &lt; 26 years

        Exclusion Criteria:

          -  Patient will be excluded from the study if any of the following are identified:

          -  Patients under legal age and in the State's custody

          -  Participant or legal guardian unable to sign Informed Consent forms

          -  Participant unable to complete study visits
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Charles Mitchell, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adriana Drada, CRC</last_name>
    <phone>305-243-4447</phone>
    <email>apd86@med.miami.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Grace Alvarez, CRC</last_name>
    <phone>305-243-4447</phone>
    <email>galvarez2@miami.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Batchelor's Children's Research Institute</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Adriana Drada, CRC</last_name>
      <phone>305-243-4447</phone>
      <email>apd86@med.miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Grace Alvarez, CRC</last_name>
      <phone>305-243-4447</phone>
      <email>galvarez2@miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Charles Mitchell, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>August 13, 2020</study_first_submitted>
  <study_first_submitted_qc>August 13, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 14, 2020</study_first_posted>
  <last_update_submitted>August 13, 2020</last_update_submitted>
  <last_update_submitted_qc>August 13, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 14, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Charles Mitchell</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Coronavirus Infections</mesh_term>
    <mesh_term>Severe Acute Respiratory Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

